Financials

  • Market Capitalization 153.7 M
  • Employee 29
  • Founded 2015
  • CEO N/A
  • Website nrxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00JCWDN63
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.03
Rapporto prezzo/fatturato
47.35

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3735
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.64 USD0.00%+3.23%-37.25%+55.15%155.81 M USD
3740
TNYA
Tenaya Therapeutics, Inc. - Common Stock
0.69 USD-1.43%-1.43%-5.48%-38.39%154.72 M USD
3748
INDP
Indaptus Therapeutics, Inc. - Common Stock
1.14 USD-1.72%-8.06%-36.67%-40.00%151.90 M USD
3751
EQ
Equillium, Inc. - Common Stock
2.39 USD-2.45%+4.37%+4.37%+43.11%151.55 M USD

Notizie